Abbvie Inc
SIX:ABBV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbvie Inc
SIX:ABBV
|
US |
|
N
|
Neste Oyj
XMUN:NEF
|
FI |
|
Kao Corp
OTC:KAOCF
|
JP |
Wall St Price Targets
ABBV Price Targets Summary
Abbvie Inc
According to Wall Street analysts, the average 1-year price target for ABBV is 108.52 CHF with a low forecast of 78.62 CHF and a high forecast of 136.24 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABBV's stock price target?
Price Target
108.52
CHF
According to Wall Street analysts, the average 1-year price target for ABBV is 108.52 CHF with a low forecast of 78.62 CHF and a high forecast of 136.24 CHF.
What is the Revenue forecast for Abbvie Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Abbvie Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for Abbvie Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 12%.
What is the Pre-Tax Income forecast for Abbvie Inc?
Projected CAGR
82%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 82%.
What is the Net Income forecast for Abbvie Inc?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 8 years is 31%.
